Approval · Notice of Compliance 29687 · 2022
ACCURETIC: Notice of Compliance 29687
Issued December 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29687
- Date
- December 13, 2022
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACCURETIC | Not yet assigned | — |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- QUINAPRIL HCL 10 MG per TAB
- QUINAPRIL HCL 20 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB